Exagen (XGN) Operating Expenses (2018 - 2026)

Exagen (XGN) has 9 years of Operating Expenses data on file, last reported at $13.6 million in Q1 2026.

• Quarterly Operating Expenses rose 9.06% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.0 million (up 13.36% YoY) and the FY2025 annual result came in at $52.9 million, up 13.09% from the prior year.
• Operating Expenses declined to $13.6 million in Q1 2026, from $14.2 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $27.3 million in Q4 2022 to a low of -$4.2 million in Q4 2023.
• A 5-year average of $15.1 million and a median of $13.6 million in 2026 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2023 — Operating Expenses slumped 115.3% — and 2024, when it surged 383.73%.
• Tracing XGN's Operating Expenses over 5 years: stood at $27.3 million in 2022, then slumped by 115.3% to -$4.2 million in 2023, then surged by 383.73% to $11.9 million in 2024, then climbed by 19.57% to $14.2 million in 2025, then declined by 3.96% to $13.6 million in 2026.
• The last three Operating Expenses figures came in at $13.6 million (Q1 2026), $14.2 million (Q4 2025), and $13.2 million (Q3 2025), per Business Quant data.